378 related articles for article (PubMed ID: 26468085)
1. Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin.
Anguizola J; Debolt E; Suresh D; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():175-181. PubMed ID: 26468085
[TBL] [Abstract][Full Text] [Related]
2. Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albumin.
Matsuda R; Li Z; Zheng X; Hage DS
J Chromatogr A; 2015 Aug; 1408():133-44. PubMed ID: 26189669
[TBL] [Abstract][Full Text] [Related]
3. The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.
Joseph KS; Hage DS
J Pharm Biomed Anal; 2010 Nov; 53(3):811-8. PubMed ID: 20537832
[TBL] [Abstract][Full Text] [Related]
4. Analysis of glipizide binding to normal and glycated human serum albumin by high-performance affinity chromatography.
Matsuda R; Li Z; Zheng X; Hage DS
Anal Bioanal Chem; 2015 Jul; 407(18):5309-21. PubMed ID: 25912461
[TBL] [Abstract][Full Text] [Related]
5. Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids.
Basiaga SB; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(30):3193-7. PubMed ID: 20974553
[TBL] [Abstract][Full Text] [Related]
6. Chromatographic analysis of acetohexamide binding to glycated human serum albumin.
Joseph KS; Anguizola J; Jackson AJ; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2775-81. PubMed ID: 20829128
[TBL] [Abstract][Full Text] [Related]
7. Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.
Matsuda R; Jobe D; Beyersdorf J; Hage DS
J Chromatogr A; 2015 Oct; 1416():112-20. PubMed ID: 26381571
[TBL] [Abstract][Full Text] [Related]
8. High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin.
Matsuda R; Anguizola J; Joseph KS; Hage DS
Anal Bioanal Chem; 2011 Nov; 401(9):2811-9. PubMed ID: 21922305
[TBL] [Abstract][Full Text] [Related]
9. Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns.
Tao P; Li Z; Matsuda R; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():64-73. PubMed ID: 30205233
[TBL] [Abstract][Full Text] [Related]
10. Binding of tolbutamide to glycated human serum albumin.
Joseph KS; Anguizola J; Hage DS
J Pharm Biomed Anal; 2011 Jan; 54(2):426-32. PubMed ID: 20880646
[TBL] [Abstract][Full Text] [Related]
11. Generation of affinity maps for thiazolidinediones with human serum albumin using affinity microcolumns. I. Studies of effects by glycation on multisite drug binding.
Sharmeen S; Woolfork A; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1236():124070. PubMed ID: 38460447
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography.
Tao P; Li Z; Woolfork AG; Hage DS
J Pharm Biomed Anal; 2019 Mar; 166():273-280. PubMed ID: 30682693
[TBL] [Abstract][Full Text] [Related]
13. Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin.
Matsuda R; Anguizola J; Joseph KS; Hage DS
J Chromatogr A; 2012 Nov; 1265():114-22. PubMed ID: 23092871
[TBL] [Abstract][Full Text] [Related]
14. Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin.
Jackson AJ; Anguizola J; Pfaunmiller EL; Hage DS
Anal Bioanal Chem; 2013 Jul; 405(17):5833-41. PubMed ID: 23657448
[TBL] [Abstract][Full Text] [Related]
15. Understanding the effects of two bound glucose in Sudlow site I on structure and function of human serum albumin: theoretical studies.
Awang T; Wiriyatanakorn N; Saparpakorn P; Japrung D; Pongprayoon P
J Biomol Struct Dyn; 2017 Mar; 35(4):781-790. PubMed ID: 26942862
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.
Joseph KS; Moser AC; Basiaga SB; Schiel JE; Hage DS
J Chromatogr A; 2009 Apr; 1216(16):3492-500. PubMed ID: 18926542
[TBL] [Abstract][Full Text] [Related]
17. Studies of verapamil binding to human serum albumin by high-performance affinity chromatography.
Mallik R; Yoo MJ; Chen S; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):69-75. PubMed ID: 18980867
[TBL] [Abstract][Full Text] [Related]
18. Analysis of drug-protein interactions by high-performance affinity chromatography: interactions of sulfonylurea drugs with normal and glycated human serum albumin.
Matsuda R; Anguizola J; Hoy KS; Hage DS
Methods Mol Biol; 2015; 1286():255-77. PubMed ID: 25749961
[TBL] [Abstract][Full Text] [Related]
19. Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin.
Anguizola JA; Basiaga SB; Hage DS
Curr Metabolomics; 2013 Sep; 1(3):239-250. PubMed ID: 24349966
[TBL] [Abstract][Full Text] [Related]
20. High-Performance affinity chromatographic studies of repaglinide and nateglinide interactions with normal and glyoxal- or methylglyoxal-modified human albumin serum.
Ovbude ST; Tao P; Li Z; Hage DS
J Pharm Biomed Anal; 2021 Jul; 201():114097. PubMed ID: 33933705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
